Dr. Jose Diaz, MD
What this data tells you about Dr. Diaz
Dr. Jose Diaz is a pulmonary disease in Leesburg, FL, with 19 years in practice. Based on federal Medicare data, Dr. Diaz performed 8,971 Medicare services across 5,639 unique beneficiaries.
Between the years covered by Open Payments, Dr. Diaz received a total of $146,549 from 61 pharmaceutical and/or device companies across 932 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Diaz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 1,312 | $64 | $141 |
| Hospital follow-up visit, moderate complexity | 981 | $61 | $126 |
| Office visit, established patient (30-39 min) | 558 | $91 | $209 |
| Test to measure expiratory airflow and volume | 537 | $19 | $71 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 530 | $29 | $80 |
| Remote patient monitoring management, 20 min/month | 468 | $36 | $101 |
| Test to determine lung volumes using gas dilution or washout | 443 | $31 | $83 |
| Test to examine how well the lungs exchange gases | 441 | $40 | $105 |
| Test to measure largest amount of air breathed in an out | 422 | $11 | $48 |
| Test to measure the level of nitric oxide gas | 363 | $13 | $41 |
| Remote patient monitoring device, 30 days | 359 | $35 | $122 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 340 | $27 | $119 |
| New patient office visit (45-59 min) | 317 | $121 | $332 |
| Test to measure exhaled air for evaluation of lung function during rest and exercise | 306 | $38 | $100 |
| Hospital follow-up visit, high complexity | 295 | $90 | $203 |
| Drug injection, under skin or into muscle | 257 | $10 | $48 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 208 | $4 | $8 |
| Critical care, first 30-74 min | 206 | $162 | $499 |
| Initial hospital admission, high complexity | 140 | $131 | $278 |
| Ceftriaxone antibiotic injection | 112 | $0 | $25 |
| Chronic care management, first 20 min/month | 79 | $46 | $125 |
| Test for exercise-induced heart and lung stress | 60 | $112 | $200 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 57 | $14 | $37 |
| Test for exercise-induced lung stress | 49 | $24 | $119 |
| Evaluation of use of breathing device | 43 | $12 | $32 |
| New patient office visit (30-44 min) | 28 | $81 | $212 |
| Initial hospital admission, moderate complexity | 23 | $99 | $272 |
| Chronic care management, additional 20 min/month | 20 | $35 | $100 |
| Diagnostic exam of lung airway using an endoscope | 17 | $91 | $305 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pulmonary disease in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Diaz is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Diaz experienced with office visit, established patient (20-29 min)?
Does Dr. Diaz receive payments from pharmaceutical companies?
How do Dr. Diaz's costs compare to other pulmonary diseases in Leesburg?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology